Connect with us

National

Multiple sclerosis drug may help treat COVID-19 and lead to faster recovery – The Conversation AU

Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.

Published

on

post featured image

What do multiple sclerosis (MS) and the novel coronavirus have in common? Until this week, not much, but a recent clinical trial has shown a reformulation of a drug used to treat MS can potentially also be used to help patients infected with COVID-19.
SNG001 is an inhaled form of a drug called interferon-beta under development by the UK pharmaceutical company Synairgen. Interferon is normally prescribed for the treatment of symptoms relating to relapsing-remitting MS.
But the clinical trial, S…

Click here to view the original article.